您的位置: 首页 > 农业专利 > 详情页

RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES CIBLANT TIM-1
专利权人:
Celdara Medical, LLC;Celldex Therapeutics, Inc.
发明人:
HE, Li-Zhen,MARSH, Jr., Henry, C.,KELER, Tibor,STADHEIM, Terrance, A.,MURAD, Joana, M.,REDER, Jake
申请号:
EP18739365
公开号:
EP3568416A4
申请日:
2018.01.12
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The invention provides chimeric antigen receptors (CARs) that specifically bind to the T-cell immunoglobulin and mucin domain 1 (TIM-1) protein. The invention further relates to modified immune cells, e.g., T or NK cells, comprising such CARs, CAR-encoding nucleic acids, CAR-encoding vectors, and methods of making such compositions. The invention further relates to methods for therapeutic use of these CARs and modified immune cells for the treatment of a condition, disorder, or disease associated with cells expressing TIM-1 (e.g., cancer).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充